Chris Ntoumenopoulos

Chris is a Managing Director at 21 Corporate, an Australian-based corporate advisory firm, and is an entrepreneur searching the world for disruptive technologies and companies. He has extensive experience in financial markets with over 20 years of raising capital and corporate advisory. Chris is the former founding director of ResApp Health, which was acquired by Pfizer, and the former director of Race Oncology.

Chris received his Bachelor of Commerce from the University of Western Australia majoring in Money and Banking, Investment Finance and Electronic Commerce.